- Home
- SBH vs KARD Comparison
SBH vs KARD Comparison
Compare SBH & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SBH | KARD |
|---|---|---|
| Founded | 1964 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2006 | 2026 |
Fundamental Metrics
Financial Performance| Metric | SBH | KARD |
|---|---|---|
| Price | $18.48 | $14.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $20.40 | ★ $41.13 |
| AVG Volume (30 Days) | ★ 1.4M | 513.7K |
| Earning Date | 11-10-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.88 | N/A |
| EPS | ★ 2.02 | N/A |
| Revenue | ★ $3,734,567,000.00 | N/A |
| Revenue This Year | $1.57 | N/A |
| Revenue Next Year | $1.26 | $50.00 |
| P/E Ratio | $9.55 | ★ N/A |
| Revenue Growth | ★ 0.90 | N/A |
| 52 Week Low | $11.54 | $12.23 |
| 52 Week High | $21.06 | $27.00 |
Technical Indicators
Market Signals| Indicator | SBH | KARD |
|---|---|---|
| Relative Strength Index (RSI) | 54.19 | 48.64 |
| Support Level | $15.09 | $13.75 |
| Resistance Level | N/A | $15.93 |
| Average True Range (ATR) | 0.86 | 1.21 |
| MACD | 0.09 | 0.26 |
| Stochastic Oscillator | 37.87 | 47.78 |
Price Performance
Historical ComparisonAbout SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. The company operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, Netherlands, and other geographical regions. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. The products offered by the company include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About KARD Kardigan Inc. Common Stock
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.